Avanos Medical Inc (AVNS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avanos Medical Inc (AVNS) has a cash flow conversion efficiency ratio of 0.036x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($28.20 Million) by net assets ($778.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Avanos Medical Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Avanos Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Avanos Medical Inc (AVNS) financial obligations for a breakdown of total debt and financial obligations.
Avanos Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avanos Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Kiwi Instruments Co. Ltd. A
SHG:688045
|
N/A |
|
Lanzhou Foci Pharmaceutical Co Ltd
SHE:002644
|
0.041x |
|
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281
|
N/A |
|
Changzhou Almaden Co Ltd
SHE:002623
|
-0.016x |
|
Ashot Ashkelon Industries Ltd
TA:ASHO
|
0.613x |
|
Forge Global Holdings Inc
NYSE:FRGE
|
-0.055x |
|
Suzhou Xingye Material Tech
SHG:603928
|
-0.007x |
|
Technocraft Industries (India) Limited
NSE:TIIL
|
0.075x |
Annual Cash Flow Conversion Efficiency for Avanos Medical Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Avanos Medical Inc from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Avanos Medical Inc (AVNS) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $778.20 Million | $74.70 Million | 0.096x | -21.02% |
| 2024-12-31 | $828.50 Million | $100.70 Million | 0.122x | +363.78% |
| 2023-12-31 | $1.24 Billion | $32.40 Million | 0.026x | -62.77% |
| 2022-12-31 | $1.29 Billion | $90.90 Million | 0.070x | +2.46% |
| 2021-12-31 | $1.27 Billion | $87.30 Million | 0.069x | +3553.25% |
| 2020-12-31 | $1.26 Billion | $-2.50 Million | -0.002x | +96.62% |
| 2019-12-31 | $1.27 Billion | $-74.50 Million | -0.059x | +47.54% |
| 2018-12-31 | $1.30 Billion | $-145.60 Million | -0.112x | -194.60% |
| 2017-12-31 | $1.22 Billion | $144.20 Million | 0.119x | -30.72% |
| 2016-12-31 | $1.10 Billion | $188.80 Million | 0.171x | +85.16% |
| 2015-12-31 | $1.06 Billion | $97.60 Million | 0.092x | -6.75% |
| 2014-12-31 | $1.49 Billion | $147.90 Million | 0.099x | -7.86% |
| 2013-12-31 | $2.08 Billion | $223.80 Million | 0.108x | +9.22% |
| 2012-12-31 | $2.06 Billion | $202.60 Million | 0.099x | -- |
| 2011-12-31 | $0.00 | $139.60 Million | x | -- |
About Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more